Biophytis S.A.
BPTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.06 | 0.46 | 0.51 |
| FCF Yield | -39.75% | -30.00% | -4.36% | -1.26% |
| EV / EBITDA | -2.58 | -2.85 | -20.58 | -58.74 |
| Quality | ||||
| ROIC | -285.79% | -181.08% | -133.87% | -108.71% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.76 | 0.78 | 0.76 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 31.55% | 20.75% | -139.52% | 35.21% |
| Safety | ||||
| Net Debt / EBITDA | -0.20 | -0.05 | 0.32 | -0.24 |
| Interest Coverage | -11.46 | -14.57 | -6.05 | -3.19 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.31 | 0.00 | 9.66 |
| Cash Conversion Cycle | -2,450.91 | -4,046.67 | -8,926.66 | -10,371.21 |